MIAMI–(BUSINESS WIRE)–TissueTech™ Received Prestigious Tibbetts Award from Small Business Administration for Its Significant Achievements in Regenerative Medicine
Author: Business Wire
Research and Markets: EpiCast Report: Glaucoma – Epidemiology Forecast to 2023
DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/z46fl6/epicast_report) has announced the addition of the “EpiCast Report: Glaucoma – Epidemiology Forecast to 2023” report to their offering. Glaucoma is a common…
Glaukos Corporation Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares
LAGUNA HILLS, Calif.–(BUSINESS WIRE)–Glaukos Corporation Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares
Second Sight Appoints Will McGuire as President and CEO
SYLMAR, Calif.–(BUSINESS WIRE)–Second Sight Medical Products, Inc. (NASDAQ:EYES) (“Second Sight” or “the Company”), a developer, manufacturer and marketer of implantable visual prosthetics that provide some useful vision to blind patients, today anno…
Glaukos Corporation Announces Pricing of Its Initial Public Offering
LAGUNA HILLS, Calif.–(BUSINESS WIRE)–Glaukos Corporation announces pricing of initial public offering.
Eleven Biotherapeutics Announces Executive Change
CAMBRIDGE, Mass.–(BUSINESS WIRE)–John McCabe, Eleven’s VP, Finance and Business Operations, is promoted to assume the roles of Principal Financial Officer and Principal Accounting Officer, reporting directly to Abbie Celniker, PhD.
Research and Markets: Corneal Neovascularization Therapeutics Pipeline Review 2015 – 4 Companies & 10 Drug Profiles
DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/fmk9dw/corneal) has announced the addition of the “Corneal Neovascularization – Pipeline Review, H1 2015” report to their offering. This report provides comprehen…
Research and Markets: Macular Edema Pipeline Review, H1 2015 – 7 Companies & 9 Drug Profiles
DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/spjbq5/macular_edema) has announced the addition of the “Macular Edema – Pipeline Review, H1 2015” report to their offering. This report provides comprehensive in…
Research and Markets: Posterior Uveitis – Pipeline Review, H1 2015
DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/t2fxnx/posterior_uveitis) has announced the addition of the “Posterior Uveitis – Pipeline Review, H1 2015” report to their offering. This report provides comprehe…
Renaissance Adds to Nationally Recognized Dental and Vision Plans in South Carolina With New Hire
INDIANAPOLIS–(BUSINESS WIRE)–Renaissance is adding nationally recognized dental and vision plans in South Carolina with new hire, Dan Pruitt.
Ocata Therapeutics Announces Positive Results Reported in a Late Breaking Abstract at the Annual Meeting of the International Society for Stem Cell Research
MARLBOROUGH, Mass.–(BUSINESS WIRE)–Ocata Therapeutics, Inc. (“Ocata” or “the Company”; NASDAQ: OCAT), a leader in the field of Regenerative Ophthalmology™, announced today that data will be presented in a Late Breaking Abstract at the International Society for Stem Cell Research (ISSCR) 13th Annual Meeting being held in Stockholm, Sweden, June 24-27. The presentation will provide a follow-up of four prospective safety trials carried out in the United States and also in South Korea. The result
New mVT® Research Shows Significant Value for AMD and DR Patients
DALLAS–(BUSINESS WIRE)–Vital Art and Science, LLC (VAS), an emerging ophthalmic medical device company, released four new studies in the continuing scientific investigations of its newly launched mVT Service, an innovative medical device that conveni…
pSivida CEO to Present at ISOPT Clinical Meeting in Berlin in July 2015
WATERTOWN, Mass.–(BUSINESS WIRE)–pSivida CEO to present at ISOPT clinical meeting in Berlin in July 2015
Mirror-like Display Creates Rich Color Pixels by Harnessing Ambient Light
WASHINGTON–(BUSINESS WIRE)–Researchers at Qualcomm MEMS Technologies have developed a display technology that harnesses natural ambient light to produce an unprecedented range of colors and superior viewing experience.
Second Sight Announces Positive Long-Term Results of the Argus II Retinal Prosthesis System
SYLMAR, Calif.–(BUSINESS WIRE)–Second Sight Medical Products, Inc. (NASDAQ:EYES) (“Second Sight” or “the Company”), a developer, manufacturer and marketer of implantable visual prosthetics to provide some useful vision to blind patients, today announced positive three year results post-implant of its Argus® II Retinal Prosthesis System (“Argus II”) from a multi-center clinical trial. The paper titled, “Long-Term Results from an Epiretinal Prosthesis to Restore Sight to the Blind”, highlights
CareCredit Supports OneSight Vision Clinic for Underserved Children at Saddleback High School
COSTA MESA, Calif.–(BUSINESS WIRE)–As part of its Caring Communities charitable program, CareCredit, from Synchrony Financial, sponsored a vision clinic with OneSight, a global vision care nonprofit providing vision care and eyewear.
Visioneering Technologies, Inc., Taps MidSouth Premier Ophthalmics as Exclusive Distributor for NaturalVue™ Lenses
ALPHARETTA, Ga.–(BUSINESS WIRE)–Visioneering Technologies, Inc., (VTI), manufacturers of NaturalVue™ Multifocal 1 Day Daily Disposable Soft Contact Lenses, has tapped MidSouth Premier Ophthalmics as exclusive distributor
Tyrogenex and Xcovery Open New Office in Needham
NEEDHAM, Mass. & PHILADELPHIA–(BUSINESS WIRE)–Tyrogenex and Xcovery today announced the opening of a new office in Needham, Mass., in partnership with the Massachusetts Life Sciences Center during the BIO International convention.
Ocata Therapeutics to Ring the NASDAQ Stock Market Opening Bell on June 24, 2015
MARLBOROUGH, Mass.–(BUSINESS WIRE)–Ocata Therapeutics, Inc. (“Ocata” or “the Company”; NASDAQ: OCAT), a leader in the field of Regenerative Ophthalmology™, today announced that Company management will ring The NASDAQ Opening Bell at 9:30 am EDT on June 24, 2015 at The NASDAQ Marketsite in New York City. “We are pleased to have been invited to open the NASDAQ and as a leader in regenerative ophthalmology are delighted to be part of this leading stock exchange,” said Paul K. Wotton Ph.D., Presi
Sikka Software Raises $10.5 Million Series C Round to Increase its Rapidly Expanding Share of Cloud-based Retail Healthcare
MILPITAS, Calif.–(BUSINESS WIRE)–Sikka Software, the leading retail healthcare cloud platform, raised its Series C funding of $10.5 million led by OrbiMed with participation from its Series B investor, Sierra Ventures and Series A investor, ATA Ventures. This new capital will further accelerate Sikka to scale sales and marketing and continue its rapid growth across key practice areas. “OrbiMed is impressed with the Sikka team and what they have accomplished to date and we are excited about th